NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

IndexRUT P/E- EPS (ttm)-0.26 Insider Own4.24% Shs Outstand209.21M Perf Week-9.37%
Market Cap1.88B Forward P/E18.50 EPS next Y0.49 Insider Trans0.00% Shs Float200.37M Perf Month-16.28%
Enterprise Value2.42B PEG- EPS next Q0.00 Inst Own84.27% Short Float11.52% Perf Quarter20.00%
Income-53.47M P/S3.74 EPS this Y125.16% Inst Trans5.69% Short Ratio4.96 Perf Half Y16.58%
Sales503.49M P/B- EPS next Y349.58% ROA-11.28% Short Interest23.08M Perf YTD19.68%
Book/sh-2.16 P/C6.38 EPS next 5Y- ROE- 52W High11.31 -20.42% Perf Year47.30%
Cash/sh1.41 P/FCF- EPS past 3/5Y25.20% 14.52% ROIC-15.72% 52W Low6.01 49.63% Perf 3Y-16.36%
Dividend Est.- EV/EBITDA70.18 Sales past 3/5Y42.07% 55.97% Gross Margin96.64% Volatility4.80% 3.65% Perf 5Y113.27%
Dividend TTM- EV/Sales4.80 EPS Y/Y TTM75.79% Oper. Margin6.59% ATR (14)0.40 Perf 10Y-40.94%
Dividend Ex-Date- Quick Ratio2.88 Sales Y/Y TTM41.67% Profit Margin-10.62% RSI (14)30.27 Recom1.18
Dividend Gr. 3/5Y- - Current Ratio2.93 EPS Q/Q100.06% SMA20-12.04% Beta1.04 Target Price16.64
Payout- Debt/Eq- Sales Q/Q56.89% SMA50-9.13% Rel Volume0.89 Prev Close8.96
Employees580 LT Debt/Eq- EarningsMay 05 BMO SMA2008.59% Avg Volume4.65M Price9.00
IPOMar 04, 1994 Option/ShortYes / Yes EPS/Sales Surpr.100.00% 13.89% Trades Volume4,135,126 Change0.45%
Date Action Analyst Rating Change Price Target Change
Apr-29-25Initiated Cantor Fitzgerald Overweight $20
Feb-25-25Initiated Wedbush Outperform $15
Nov-20-23Resumed JP Morgan Overweight $10
Sep-18-23Upgrade RBC Capital Mkts Sector Perform → Outperform $9 → $10
Aug-04-23Upgrade Jefferies Hold → Buy $11
Jul-13-23Upgrade BofA Securities Neutral → Buy $10
Feb-22-23Upgrade Needham Hold → Buy $14
Nov-02-22Upgrade Evercore ISI In-line → Outperform $14 → $16
Aug-05-22Downgrade Oppenheimer Outperform → Perform
Aug-05-22Downgrade Evercore ISI Outperform → In-line $14
Jun-30-25 01:05PM
Jun-27-25 07:00AM
Jun-26-25 04:32AM
Jun-25-25 12:00PM
07:51AM
06:16AM Loading…
06:16AM
Jun-18-25 09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
09:40AM
07:00AM Loading…
Jun-16-25 07:00AM
Jun-13-25 07:00AM
02:32AM
Jun-06-25 07:00AM
Jun-04-25 12:00PM
10:00AM
05:52AM
Jun-03-25 07:00AM
Jun-02-25 07:00AM
May-30-25 07:00AM
May-28-25 09:40AM
May-27-25 07:00AM
May-26-25 09:55AM
May-16-25 07:00AM
May-15-25 09:40AM
07:00AM Loading…
May-14-25 07:00AM
May-09-25 10:00AM
07:08AM
May-08-25 12:20PM
12:00PM
09:55AM
May-06-25 04:50AM
03:02AM
12:56AM
May-05-25 02:05PM
12:54PM
08:20AM
07:00AM
May-02-25 07:00AM
May-01-25 07:00AM
Apr-30-25 10:01AM
07:00AM
Apr-28-25 10:00AM
Apr-21-25 07:00AM
Apr-10-25 05:21PM
Apr-04-25 07:00AM
Apr-02-25 04:01PM
Mar-06-25 07:00AM
Mar-01-25 09:13AM
Feb-27-25 10:30AM
Feb-26-25 09:55AM
09:55AM
Feb-25-25 02:28AM
02:01AM
Feb-24-25 06:15PM
04:30PM
08:10AM
07:17AM
07:00AM
06:00AM
Feb-19-25 07:00AM
Feb-17-25 10:00AM
Feb-12-25 07:00AM
Feb-10-25 08:30AM
07:00AM
Feb-04-25 07:00AM
Jan-14-25 08:35AM
Jan-10-25 07:00AM
Jan-07-25 07:00AM
Jan-06-25 07:00AM
Dec-04-24 04:15PM
Nov-18-24 02:00AM
Nov-06-24 07:00AM
Nov-05-24 07:29AM
07:00AM
02:32AM
02:03AM
Nov-04-24 02:30PM
08:10AM
07:06AM
07:00AM
Oct-24-24 08:00AM
Oct-23-24 09:55AM
Oct-21-24 07:00AM
Oct-17-24 03:05PM
Oct-14-24 07:00AM
Oct-11-24 12:15PM
Oct-10-24 07:00AM
Oct-09-24 08:03AM
Oct-07-24 12:00PM
Oct-03-24 07:00AM
Oct-02-24 07:00AM
Oct-01-24 07:30AM
06:53AM
Sep-30-24 07:00AM
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hutson Nancy JDirectorDec 13 '24Sale7.547,00052,78086,638Dec 16 04:35 PM
Hutson Nancy JDirectorDec 13 '24Proposed Sale7.517,00052,584Dec 13 04:23 PM